𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of memantine in people with moderate to severe Alzheimer's disease with and without background donepezil therapy: Pooled analysis of four randomized trials

✍ Scribed by Graham, Stephen; Hendrix, Suzanne; Miller, Michael; Pejovic, Vojislav; Tocco, Michael


Book ID
123503037
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
49 KB
Volume
9
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Tolerability of switching from donepezil
✍ Gunhild Waldemar; Maritta HyvΓ€rinen; Mette Krog Josiassen; Alex KΓΈrner; Heikki L πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 44 KB πŸ‘ 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving

Efficacy and safety of donepezil in pati
✍ Howard Feldman; Serge Gauthier; Jane Hecker; Bruno Vellas; Yikang Xu; John R. Ie πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 634 KB

## Abstract ## Background There have been very limited investigations of cholinesterase inhibitor therapy in more advanced stages of Alzheimer's disease (AD). The efficacy and safety of donepezil were evaluated in __post hoc__ analyses of a subgroup of patients with more severe AD (standardized Mi